IDiyas

For the Inventor, By the Inventor

Barcelona, Spain

Laboratorios Del Dr. Esteve S.a.


USPTO Granted Patents = 150



Trademarks = 7

Forward Citations = 577

Loading Chart...
Loading Chart...

289 inventors (with patents filed for the assignee):

goldMedal Jordi Frigola-Constansa (32 out of 40 patents)

silverMedal Helmut Heinrich Buschmann (17 out of 59 patents)

bronzeMedal Alberto Dordal Zueras (15 out of 18 patents)

4.  Ramon Merce-Vidal (14 out of 18 patents)

5.  Antoni Torrens Jover (13 out of 18 patents)

6.  Maria Rosa Cuberes-Altisent (13 out of 15 patents)

7.  Joerg Holenz (13 out of 26 patents)

8.  Carmen Almansa-Rosales (12 out of 36 patents)

9.  Jordi F Constansa (8 out of 8 patents)

10.  Juan P Corominas (8 out of 8 patents)

11.  Juan Pares-Corominas (8 out of 8 patents)

12.  Susana Yenes Minguez (7 out of 7 patents)

13.  Luz Romero Alonso (7 out of 8 patents)

14.  Josep Mas Prió (7 out of 10 patents)

15.  Augusto C Pinol (7 out of 7 patents)


Core Competencies:
HIV Treatment
Multiepitope Immunogen
Pain Management
Sigma Receptor Modulators
Co-Crystals
Opioid Analgesics
Tramadol Derivatives
SNRIs
Dendritic Cell Inhibition
Diabetes Pain Management
Pharmaceutical Compositions
Analgesic Potentiation

150 patents:

1. 11325946 - Method of treating HIV-1 infection utilizing a multiepitope T cell immunogen comprising gag, pol, vif and nef epitopes (2022-05-10),
2. 10815278 - Immunogens for HIV vaccination (2020-10-27),
3. 10351549 - Amide derivatives having multimodal activity against pain (2019-07-16),
4. 10246465 - Alkyl derivatives of 1-oxa-4,9-diazaspiro undecane compounds having multimodal activity against pain (2019-04-02),
5. 10245276 - Co-crystals of tramadol and coxibs (2019-04-02),
6. 10238668 - Co-crystals of tramadol and coxibis (2019-03-26),
7. RE47214 - 4-[-2-[[5-methyl-1-(2-naphtalenyl)-1H-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride polymorphs and solvates (2019-01-28),
8. 10189828 - 1-methylpyrazole-piperazine compounds having multimodal activity against pain (2019-01-29),
9. 10183918 - Oxa-azaspiro compounds having activity against pain (2019-01-22),
10. 9981942 - Piperidine derivatives having multimodal activity against pain (2018-05-29),
11. 9963453 - Substituted pyrazino[1,2-a]indoles as sigma receptor activity modulators (2018-05-08),
12. 9952218 - Methods for identifying HIV neutralizing antibodies (2018-04-24),
13. 9931346 - Serotonin-norepinephrine reuptake inhibitors (SNRIs) and Sigma receptor ligands combinations (2018-04-03),
14. 9914705 - 1-aryl-3-aminoalkoxy pyrazoles as sigma ligands enhancing analgesic effect of opioids and attenuating the dependency thereof (2018-03-13),
15. 9902711 - Piperidine compounds having multimodal activity against pain (2018-02-27),
Laboratorios del Dr. Esteve S.A. is a pharmaceutical company headquartered in Barcelona, Spain. With more than 90 years of experience, the company specializes in the research, development, and production of innovative medicinal products. Esteve's portfolio includes a wide range of therapeutic areas such as neuroscience, pain management, gastroenterology, and urology. Committed to improving patients' quality of life, Esteve focuses on providing reliable and effective treatments worldwide.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

150 Patents

#2 in Barcelona

#5 in Spain

#5,295 in the World

...
Barcelona, Spain

Laboratorios Del Dr. Esteve S.a.

Forward Citations = 577

289 inventors:

goldMedal Jordi Frigola-Constansa (32 out of 40 patents)

silverMedal Helmut Heinrich Buschmann (17 out of 59 patents)

bronzeMedal Alberto Dordal Zueras (15 out of 18 patents)

4.  Ramon Merce-Vidal (14 out of 18 patents)

5.  Antoni Torrens Jover (13 out of 18 patents)

Please report any incorrect information to support@idiyas.com
Loading…